3′-Hydroxy Repaglinide(Mixture of Diastereomers) (CAS 874908-14-2)
QUICK LINKS
3′-Hydroxy Repaglinide (Mixture of Diastereomers) is a derivative of repaglinide, belonging to the glinide family and serving as an analog of meglitinide. Notably, it incorporates the addition of a hydroxyl group at the 3′-position. Acting as a glucose-lowering agent, 3′-OH-Repaglinide stimulates the release of insulin from the pancreas. Its mode of action involves binding to the sulfonylurea receptor (SUR) situated on the beta cells within the pancreas. This binding event prompts the closure of ATP-sensitive potassium channels, subsequently inducing an influx of calcium ions into the cells. As a result, the increased calcium ion influx triggers the release of insulin from the beta cells, ultimately leading to a reduction in blood glucose levels.
3′-Hydroxy Repaglinide(Mixture of Diastereomers) (CAS 874908-14-2) References
- Montelukast: a review of its therapeutic potential in persistent asthma. | Jarvis, B. and Markham, A. 2000. Drugs. 59: 891-928. PMID: 10804041
- The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide. | Niemi, M., et al. 2001. Clin Pharmacol Ther. 70: 58-65. PMID: 11452245
- Clinical pharmacokinetics and pharmacodynamics of repaglinide. | Hatorp, V. 2002. Clin Pharmacokinet. 41: 471-83. PMID: 12083976
- Selective inhibition of human cytochrome P4502C8 by montelukast. | Walsky, RL., et al. 2005. Drug Metab Dispos. 33: 413-8. PMID: 15608135
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3′-Hydroxy Repaglinide(Mixture of Diastereomers), 1 mg | sc-209743 | 1 mg | $495.00 |